Literature DB >> 30830487

Selective galactose culture condition reveals distinct metabolic signatures in pyruvate dehydrogenase and complex I deficient human skin fibroblasts.

Damian Hertig1,2,3, Andrea Felser2, Gaëlle Diserens1, Sandra Kurth2, Peter Vermathen1, Jean-Marc Nuoffer4,5.   

Abstract

INTRODUCTION: A decline in mitochondrial function represents a key factor of a large number of inborn errors of metabolism, which lead to an extremely heterogeneous group of disorders.
OBJECTIVES: To gain insight into the biochemical consequences of mitochondrial dysfunction, we performed a metabolic profiling study in human skin fibroblasts using galactose stress medium, which forces cells to rely on mitochondrial metabolism.
METHODS: Fibroblasts from controls, complex I and pyruvate dehydrogenase (PDH) deficient patients were grown under glucose or galactose culture condition. We investigated extracellular flux using Seahorse XF24 cell analyzer and assessed metabolome fingerprints using NMR spectroscopy.
RESULTS: Incubation of fibroblasts in galactose leads to an increase in oxygen consumption and decrease in extracellular acidification rate, confirming adaptation to a more aerobic metabolism. NMR allowed rapid profiling of 41 intracellular metabolites and revealed clear separation of mitochondrial defects from controls under galactose using partial least squares discriminant analysis. We found changes in classical markers of mitochondrial metabolic dysfunction, as well as unexpected markers of amino acid and choline metabolism. PDH deficient cell lines showed distinct upregulation of glutaminolytic metabolism and accumulation of branched-chain amino acids, while complex I deficient cell lines were characterized by increased levels in choline metabolites under galactose.
CONCLUSION: Our results show the relevance of selective culture methods in discriminating normal from metabolic deficient cells. The study indicates that untargeted fingerprinting NMR profiles provide physiological insight on metabolic adaptations and can be used to distinguish cellular metabolic adaptations in PDH and complex I deficient fibroblasts.

Entities:  

Keywords:  Complex I; Galactose; Mitochondrial dysfunction; NMR; Pyruvate dehydrogenase

Year:  2019        PMID: 30830487     DOI: 10.1007/s11306-019-1497-2

Source DB:  PubMed          Journal:  Metabolomics        ISSN: 1573-3882            Impact factor:   4.290


  39 in total

1.  Medicine. A common pathway for a rare disease?

Authors:  Scott B Vafai; Vamsi K Mootha
Journal:  Science       Date:  2013-12-20       Impact factor: 47.728

2.  Leber's hereditary optic neuropathy with the 11 778 mtDNA mutation and white matter disease resembling multiple sclerosis: clinical, MRI and MRS findings.

Authors:  P H Jansen; M S van der Knaap; I F de Coo
Journal:  J Neurol Sci       Date:  1996-02       Impact factor: 3.181

Review 3.  Human complex I deficiency: clinical spectrum and involvement of oxygen free radicals in the pathogenicity of the defect.

Authors:  B H Robinson
Journal:  Biochim Biophys Acta       Date:  1998-05-06

Review 4.  Disorders of pyruvate carboxylase and the pyruvate dehydrogenase complex.

Authors:  B H Robinson; N MacKay; K Chun; M Ling
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

5.  Developmental changes in choline- and ethanolamine-containing compounds measured with proton-decoupled (31)P MRS in in vivo human brain.

Authors:  S Blüml; K J Seymour; B D Ross
Journal:  Magn Reson Med       Date:  1999-10       Impact factor: 4.668

Review 6.  Pyruvate dehydrogenase deficiency.

Authors:  G K Brown; L J Otero; M LeGris; R M Brown
Journal:  J Med Genet       Date:  1994-11       Impact factor: 6.318

Review 7.  Branched-chain amino acid metabolism.

Authors:  A E Harper; R H Miller; K P Block
Journal:  Annu Rev Nutr       Date:  1984       Impact factor: 11.848

Review 8.  OXPHOS mutations and neurodegeneration.

Authors:  Werner J H Koopman; Felix Distelmaier; Jan A M Smeitink; Peter H G M Willems
Journal:  EMBO J       Date:  2012-11-13       Impact factor: 11.598

9.  Metabolic Profiling of Cells in Response to Drug Treatment using 1H High-resolution Magic Angle Spinning (HR-MAS) NMR Spectroscopy.

Authors:  Martina Vermathen; Gaëlle Diserens; Peter Vermathen; Julien Furrer
Journal:  Chimia (Aarau)       Date:  2017-03-29       Impact factor: 1.509

10.  Energy substrate modulates mitochondrial structure and oxidative capacity in cancer cells.

Authors:  Rodrigue Rossignol; Robert Gilkerson; Robert Aggeler; Kunihiro Yamagata; S James Remington; Roderick A Capaldi
Journal:  Cancer Res       Date:  2004-02-01       Impact factor: 12.701

View more
  1 in total

1.  Determination of Intra- and Extracellular Metabolic Adaptations of 3D Cell Cultures upon Challenges in Real-Time by NMR.

Authors:  Christian Urzì; Damian Hertig; Christoph Meyer; Sally Maddah; Jean-Marc Nuoffer; Peter Vermathen
Journal:  Int J Mol Sci       Date:  2022-06-12       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.